RecruitingNot Applicable

Development of Motility and Cognition in Infants

Finland250 participantsStarted 2021-10-01

Plain-language summary

PILKE study uses wearables for assessing motor development in infants in order to define functional growth trajectories in the normal infants and infants at risk of neurological compromise. In addition, PILKE studies correlation of early motor development to later neurocognitive development.

Who can participate

Age range5 Months – 26 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age at enrollment 5-8mos * typically developing Exclusion Criteria: * all neurologically significant medical histories during pregnancy, at birth or postnatally * suspicion of developmental delay * suspicion or diagnosis of syndromes with neuromotor symptoms

What they're measuring

neurocognitive development

Timeframe: 24 months

neurological development

Timeframe: 12 months

Trial details

NCT IDNCT05527080

SponsorHelsinki University Central Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-30

Contact for this trial

Sampsa Vanhatalo, prof

00358505286119 sampsa.vanhatalo@helsinki.fi

View on ClinicalTrials.gov More Neurodevelopmental Disorders trials